Clinical trials
Withdrawn Phase 2 Lymphoma trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
40 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2002 | 1 |
| 2004 | 1 |
| 2005 | 1 |
| 2006 | 2 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 3 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 1 |
| 2015 | 2 |
| 2016 | 3 |
| 2017 | 1 |
| 2018 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 2 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 40 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| M.D. Anderson Cancer Center | 5 |
| Hoag Memorial Hospital Presbyterian | 3 |
| National Cancer Institute (NCI) | 2 |
| SecuraBio | 2 |
| University of California, San Francisco | 2 |
| AHS Cancer Control Alberta | 1 |
| AIDS Malignancy Consortium | 1 |
| Bristol-Myers Squibb | 1 |
| Case Comprehensive Cancer Center | 1 |
| Columbia University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma | 40 |
| Lymphoma, Large B-Cell, Diffuse | 9 |
| Lymphoma, Non-Hodgkin | 9 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 8 |
| Lymphoma, Follicular | 8 |
| Recurrence | 8 |
| Burkitt Lymphoma | 7 |
| Hodgkin Disease | 7 |
| Waldenstrom Macroglobulinemia | 7 |
| Leukemia | 6 |
Trials
Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.